logo
Guinness-owner Diageo posts 28% decline in profit following 'challenging' year

Guinness-owner Diageo posts 28% decline in profit following 'challenging' year

Irish Examiner12 hours ago
Guinness-owner Diageo has posted a near 28% decline in operating profit during its latest financial year as the company faced slower sales, restructuring costs, and unfavourable foreign exchange rates.
In its preliminary results for its 2025 financial year ending on June 30, Diageo reported net sales of $20.2bn (€17.45bn) - down 0.1% compared to the previous year - with the company citing unfavourable foreign exchange as well as acquisition and disposal adjustments.
The company's operating profit fell to $4.3bn - down 27.8%. It said this was primarily due to exceptional impairment and restructuring costs, unfavourable foreign exchange and a decline in organic operating margin.
In January, the company also raised prices on pints of Guinness as well as its other brands marking the fourth price hike in two years.
Diageo's net cash flow from operating activities increased by $200m to $4.3bn. Its net debt as of the end of June was $21.9bn.
The company recommended a full-year dividend of $1.03 per share.
Interim chief executive of Diageo Nik Jhangiani said the fiscal year had been "challenging" but the results were 'in line with our guidance'.
'While we are encouraged by areas of progress and the standout performance from Don Julio, Guinness and Crown Royal Blackberry, there is clearly much more to do across our broader portfolio and brands,' he said.
'We are also committed to strengthening our balance sheet and expect to deliver around $3bn free cash flow in fiscal 26, increasing financial flexibility whilst continuing to invest for longer term growth.'
In terms of its outlook for the current financial year, the company said it is focused on driving productivity and meeting its cost savings target which has increased from $500m to $625m.
'In fiscal 26, expect organic sales growth to be similar to fiscal 25 and organic operating profit growth to be mid-single-digit, including the impact of tariffs as at this time,' the company said.
However, the company will now have to contend with the new tariff regime implemented by US president Donald Trump which could impact sales in one of its biggest markets.
Despite the economic uncertainty, and the mounting pressure on consumers, Mr Jhangiani said he 'believe in the attractive long-term fundamentals of our industry and in our ability to continue to outperform' the rest of the industry.
'We are focused on what we can manage and control and executing at pace. The Board and management are committed to delivering improved financial performance and stronger shareholder returns on a sustained basis.'
There has been turmoil at Diageo in recent weeks following the shock departure last month of its chief executive Debra Crew after a bruising run in which the company's stock has plummeted.
Her tenure has been punctuated by setbacks including a drop in sales on cooling demand in China and the US, and a profit warning after being caught out by piles of unsold inventory in Mexico and Brazil.
The company was forced to scrap its long-held medium-term sales target in February as a result of higher trade friction denting consumer confidence.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Megan O'Brien: Diageo shares rose 7% after its latest results - it's too early to toast a recovery
Megan O'Brien: Diageo shares rose 7% after its latest results - it's too early to toast a recovery

Business Post

time4 hours ago

  • Business Post

Megan O'Brien: Diageo shares rose 7% after its latest results - it's too early to toast a recovery

Business Post subscribers can read: • What Diageo's new interim CEO had to say about $200m in Trump tariffs — and how they plan to cushion the blow • How alcohol-free brands like Guinness 0.0 and Captain Morgan 0.0 are quietly driving double-digit growth • Why the promise of a new CEO by October gave investors a rare shot of confidence Shares in drinks giant Diageo rose almost 7 per cent on Tuesday morning. It's worth noting the gain was the Guinness-owner's biggest rally - on ...

Trump tariffs expected to cost Guinness parent company 200 million
Trump tariffs expected to cost Guinness parent company 200 million

Irish Post

time4 hours ago

  • Irish Post

Trump tariffs expected to cost Guinness parent company 200 million

DIAGEO, the global drinks giant behind Guinness and Johnnie Walker, is facing a tough year shaped by trade tariffs and shifting consumer trends. Despite these challenges, Guinness continues to be a strong performer for the company. The company now expects a $200 million annual hit from US tariffs introduced under President Trump, a jump from the $150 million impact it previously forecast. Diageo says it can absorb around half of the blow through supply chain improvements and inventory management. At the same time, profits have taken a hit. Operating profit fell nearly 28% in the year to June, and shares have dropped more than 25% in 2025, making Diageo one of the FTSE 100's worst performers. The company also continues to feel the effects of changing drinking habits, with younger consumers drinking less and many switching to cheaper options amid economic pressures. The departure of CEO Debra Crew last month has added to investor unease. She stepped down after just over a year in the role, following a series of underwhelming results. Nik Jhangiani, Diageo's CFO, is serving as interim CEO and has expanded the company's cost-saving plan from £500 million to £625 million over three years. He stated the cuts won't focus solely on reducing headcount. Amid the turbulence, Guinness remains a bright spot. UK sales rose 6.7%, although supply issues limited further gains. Don Julio tequila and Crown Royal Blackberry have also shown strong demand. Diageo expects organic sales growth to remain around 1.7%, matching last year's performance. The company is still searching for a permanent CEO to lead a turnaround as it faces mounting pressure to stabilise operations and restore shareholder confidence. See More: Donald Trump, Guinness, Tariffs, US Trade Tariffs

Trump flags new pharma tariff to come next week, and says EU deal gave him $600bn ‘to invest in anything I want'
Trump flags new pharma tariff to come next week, and says EU deal gave him $600bn ‘to invest in anything I want'

Irish Independent

time5 hours ago

  • Irish Independent

Trump flags new pharma tariff to come next week, and says EU deal gave him $600bn ‘to invest in anything I want'

Today at 10:28 US president Donald Trump said US tariffs on pharmaceutical imports and on semiconductors would be announced 'within the next week or so', as the administration prepares to target key economic sectors in its effort to remake global trade. The EU says its 15pc tariff deal with the US means drugs are already covered. 'We'll be putting an initially small tariff on pharmaceuticals, but in one year, one and a half years maximum, it's going to go to 150pc and then it's going to go to 250pc because we want pharmaceuticals made in our country,' Mr Trump said yesterday in an interview on CNBC. He name-checked China and Ireland as countries where drugs are currently made for the US market. In an on-air interview by phone, President Trump outlined details of the framework trade deal with the EU that was struck just over a week ago, but has yet to produce a final joint-statement signed off by both the EU and United States setting out the practicalities. Mr Trump said a commitment by the EU side to invest $600bn in the US was 'not a loan'. 'They gave me $600bn and that's a gift, that is not a loan,' he said. 'They gave us the $600bn that we can invest in anything we want. I can do anything I want with it.' If the EU does not pay then it will face tariffs of 30pc, he said. Mr Trump has threatened debilitating tariffs on the drug industry in an effort to force manufacturing back to the US. He recently demanded major suppliers of medicines drastically cut costs or face additional, unspecified penalties. The sectoral tariffs on pharmaceuticals, metals and other industries stem from trade investigations that can last about nine months and are imposed on national security grounds under Section 232 of the Trade Expansion Act. ADVERTISEMENT It is seen as stronger legal footing than the emergency powers Trump used for his country-specific levies, which face court challenges. Those so-called reciprocal tariffs are slated to go into effect tomorrow. The European Commission insists any new global tariff on pharma will not be added to the 15pc it has agreed as an across-the-board tariff The commission says the 15pc ceiling will also apply to any potential future tariffs on pharmaceuticals and semiconductors, including those based on Section 232. 'We're going to be announcing on semiconductors and chips, which is a separate category,' Mr Trump added.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store